Web Analytics

3 Latest Announced Rounds

  • $2,500,000
    Unknown

    1 Investors

    Services for Renewable Energy
    Nov 22nd, 2024
  • $3,700,000
    Pre-Series B

    1 Investors

    Financial Services
    Nov 22nd, 2024
  • $45,000,000
    Series C

    1 Investors

    Renewable Energy Semiconductor Manufacturing
    Nov 22nd, 2024
$2,202.93M Raised in 92 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Ability Biologics

start up
Canada - Montreal, Quebec
  • 07/12/2023
  • Seed
  • $12,000,000

Our Mission:
Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.

The premier biotherapeutic targeting company

Our powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics.

We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need.


Related People

Giles DayCo Founder

Giles Day United States - South San Francisco, California

N/A